Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and ProposalsStefanie T. Jost, Marie‐Ann Kaldenbach, Angelo Antonini et al.|Movement Disorders|2023Cited by 351
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathiesIlaria Poggiolini, Laura Parkkinen, Vandana Ayyar Gupta et al.|Brain|2021Cited by 190
AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trialsDaniela Berg, Baltazar Gomez‐Mancilla, Jana Godau et al.|Movement Disorders|2011Cited by 173
AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding studyFabrizio Stocchi, Claudia Trenkwalder, Olivier Rascol et al.|Movement Disorders|2013Cited by 137
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Johannes Schwarz, Werner Poewe et al.|The Lancet Neurology|2019Cited by 126